Ligand profile
EPR
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_03503 — Aldo/keto reductase family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
EPR- PDB
6kiy- UniProt (similar protein)
Q9X265- Target protein
- KP13_03503
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 57.6
- −1 ≤ LogP ≤ 5 2.92
- MW ≤ 500 Da 319.4
- LogP ≤ 5 2.92
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 57.6
Matches PAINS filter: ene_rhod_A(235). May be a frequent false positive in HTS — review carefully.
Chemical representations
Canonical representations for cheminformatics workflows.
C/C(=C\c1ccccc1)/C=C2C(=O)N(C(=S)S2)CC(=O)OC/C(=C\c1ccccc1)/C=C2C(=O)N(C(=S)S2)CC(=O)O
InChI=1S/C15H13NO3S2/c1-10(7-11-5-3-2-4-6-11)8-12-14(19)16(9-13(17)18)15(20)21-12/h2-8H,9H2,1H3,(H,17,18)/b10-7+,12-8?InChI=1S/C15H13NO3S2/c1-10(7-11-5-3-2-4-6-11)8-12-14(19)16(9-13(17)18)15(20)21-12/h2-8H,9H2,1H3,(H,17,18)/b10-7+,12-8?
CHNUOJQWGUIOLD-KEBJEMEDSA-NCHNUOJQWGUIOLD-KEBJEMEDSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00248
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand EPR →
- PDB RCSB structure 6kiy →
- UniProt UniProt Q9X265 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “EPR”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03503.
PDB 5
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).